Geron Corporation’s $375 Million Funding

Leila Ahmed North America Legal Chronicle
Tagged:

Fenwick & West represented Royalty Pharma in the transaction.Geron Corporation (Nasdaq: GERN) announced that Royalty Pharma (Nasdaq: PRRX), a buyer of biopharmaceutical royalties and funder of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here